<ul>
	<li>Known hypersensitivity to clomipramine and any of the excipients in the tablets.</li>
	<li>Cross-hypersensitivity to tricyclic antidepressants of the dibenzazepine group.</li>
	<li>Concomitant use with a monoamine oxidase (MAO) inhibitor, or within 14 days before or after treatment with an irreversible MAO inhibitor, or within 14 days before moclobemide, a reversible MAO inhibitor.</li>
	<li>Acute and recovery stages of myocardial infarction.</li>
	<li>Congenital long QT syndrome.</li>
</ul>